1. Home
  2. ISPC vs HEPA Comparison

ISPC vs HEPA Comparison

Compare ISPC & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISPC
  • HEPA
  • Stock Information
  • Founded
  • ISPC 2009
  • HEPA 2013
  • Country
  • ISPC United States
  • HEPA United States
  • Employees
  • ISPC N/A
  • HEPA N/A
  • Industry
  • ISPC Precision Instruments
  • HEPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISPC Health Care
  • HEPA Health Care
  • Exchange
  • ISPC Nasdaq
  • HEPA Nasdaq
  • Market Cap
  • ISPC 3.2M
  • HEPA 463.4K
  • IPO Year
  • ISPC 2021
  • HEPA N/A
  • Fundamental
  • Price
  • ISPC $1.14
  • HEPA $0.39
  • Analyst Decision
  • ISPC
  • HEPA
  • Analyst Count
  • ISPC 0
  • HEPA 0
  • Target Price
  • ISPC N/A
  • HEPA N/A
  • AVG Volume (30 Days)
  • ISPC 50.4K
  • HEPA 4.6M
  • Earning Date
  • ISPC 05-20-2025
  • HEPA 05-20-2025
  • Dividend Yield
  • ISPC N/A
  • HEPA N/A
  • EPS Growth
  • ISPC N/A
  • HEPA N/A
  • EPS
  • ISPC N/A
  • HEPA N/A
  • Revenue
  • ISPC $9,291,115.00
  • HEPA N/A
  • Revenue This Year
  • ISPC $35.93
  • HEPA N/A
  • Revenue Next Year
  • ISPC N/A
  • HEPA N/A
  • P/E Ratio
  • ISPC N/A
  • HEPA N/A
  • Revenue Growth
  • ISPC N/A
  • HEPA N/A
  • 52 Week Low
  • ISPC $1.02
  • HEPA $0.25
  • 52 Week High
  • ISPC $11.80
  • HEPA $70.00
  • Technical
  • Relative Strength Index (RSI)
  • ISPC 42.82
  • HEPA 29.53
  • Support Level
  • ISPC $1.09
  • HEPA $0.27
  • Resistance Level
  • ISPC $1.41
  • HEPA $0.49
  • Average True Range (ATR)
  • ISPC 0.08
  • HEPA 0.06
  • MACD
  • ISPC -0.00
  • HEPA 0.16
  • Stochastic Oscillator
  • ISPC 15.62
  • HEPA 60.00

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Share on Social Networks: